spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Atrial Shunt 

 HSMN NewsFeed - 12 Apr 2024
Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data
Devices Cardiology Interventional
 HSMN NewsFeed - 22 May 2023
Corvia Medical Releases Two-Year Clinical Trial Results Confirming Sustained Benefit and Safety of its Atrial Shunt in Heart Failure Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Apr 2022
Reduce LAP-HF II Analyses Show 50% of Study Patients Demonstrated Significant Clinical Benefit from the Corvia(R) Atrial Shunt
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Aug 2021
Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 19 Jan 2021
Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation for Heart Failure (HF)
Devices Cardiology FDA
 HSMN NewsFeed - 2 Dec 2020
V-Wave Announces Appointment of Bill Hughes as Chief Financial Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 17 Nov 2020
Corvia Medical Completes Randomization In REDUCE LAP-HF II Pivotal Trial And Gains FDA Authorization To Provide Continued Access For The Corvia Atrial Shunt
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 28 Apr 2020
InterShunt Technologies Announces Formation and Initial Meeting of its Scientific Advisory Board to Guide Development of its Percutaneous Atrial Shunt Catheter System for Heart Failure
Devices Cardiology Personnel
 HSMN NewsFeed - 5 Mar 2020
V-Wave Receives CE Mark for the Ventura(TM) Interatrial Shunt System
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Jan 2020
First Japanese Patients Randomized In Corvia Medical's REDUCE LAP-HF II Global Clinical Trial For Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Oct 2019
Corvia Medical's Interatrial Shunt Device (IASD(R)) Receives Breakthrough Device Designation For Heart Failure
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 6 Sep 2019
Occlutech AFR Heart Failure Device Obtains CE Mark Approval
Devices Cardiology Regulatory
 HSMN NewsFeed - 15 Aug 2019
V-Wave's Interatrial Shunt Receives FDA Breakthrough Device Designation for Heart Failure
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 12 Mar 2019
William T. Abraham, MD, joins V-Wave as Chief Medical Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 12 May 2016
Corvia Medical Announces CE Mark Approval And Enrollment Of First Patients In Randomized Clinical Study
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 28 Mar 2016
First Human Results with V-Wave’s Interatrial Shunt Published in The Lancet
Devices Cardiology
 HSMN NewsFeed - 11 Jan 2016
V-Wave Ltd. Announces $28M Series B Financing
Devices Interventional Cardiology Venture Capital
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.